Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
#Events

Category: Uncategorized

Regulatory Update: Circular No. 39/2025/TT-BYT on Delegating Authority for Pharmaceutical Tasks and Administrative Procedures

13/12/2025 Published by vivi

Circular No. 39/2025/TT-BYT, issued by the Ministry of Health (MoH) on September 20, 2025, details the delegation of certain duties... Read more

Tags: #Regulations

Regulatory Update: Decree No. 163/2025/ND-CP on Detailed Regulations and Measures for Implementing the Law on Pharmacy

13/12/2025 Published by vivi

This decree, issued by the Government of Vietnam on June 29, 2025, provides updated regulations on pharmaceutical activities, detailing several... Read more

Category: Uncategorized

Tags: #Regulations

Strategic Collaboration Signed to Advance Metabolic Disorder Treatments

13/12/2025 Published by vivi

Zealand Pharma A/S and OTR Therapeutics have announced a strategic collaboration and license agreement focused on the discovery and development... Read more

Category: Uncategorized

Tags: #Global Trends

China’s NMPA Clears Two Sanofi Treatments for Rare Hematologic Diseases

13/12/2025 Published by vivi

China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi's rare hematologic disease treatments: Qfitlia (fitusiran) and... Read more

Category: Uncategorized

Tags: #Global Trends

European Union Advances New Pharmaceutical Regulatory Framework

13/12/2025 Published by vivi

Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework... Read more

Category: Uncategorized

Tags: #Global Trends

Novel Monoclonal Antibody Gains FDA Clearance for Generalized Myasthenia Gravis

13/12/2025 Published by vivi

The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Amgen's monoclonal antibody, Uplizna (inebilizumab). The new... Read more

Category: Uncategorized

Tags: #Global Trends